Use this url to cite publication: https://hdl.handle.net/20.500.12512/81943
Efficacy and safety of Teverelix LA, a new GNRH antagonist in patients with advanced prostate cancer. Results from a phase ii multi-centre, open-label, pilot study investigating an initial
Type of publication
Tezės Web of Science duomenų bazėje / Theses in Web of Science database (T1a1)
Author(s)
| Author | Affiliation |
|---|---|
Maclean, C | |
Title
Efficacy and safety of Teverelix LA, a new GNRH antagonist in patients with advanced prostate cancer. Results from a phase ii multi-centre, open-label, pilot study investigating an initial
C. Maclean, F. Larsen, J. Drewe, A. Ulys, D. Kaniušas
Date Issued
| Date |
|---|
2007-03-21 |
Extent
p. 87.
Is part of
European urology. Supplements : 22nd congress of the European Association of urology : Berlin, Germany, 21-24 March 2007 : abstract book. Amsterdam : Elsevier Science., 2007, vol. 6, iss. 2, March.
Version
Originalus / Original
Description
abstract no. 257
Type of document
type::text::conference output::conference proceedings::conference paper
ISSN (of the container)
1569-9056
Other Identifier(s)
(LSMU ALMA)990000677470107106
Coverage Spatial
Vokietija / Germany (DE)
Language
Anglų / English (en)